Cuprina Holdings (Cayman) Limited (CUPR)
CUPR trades on Nasdaq in Health Care, Industrial Specialties. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.90
-7.77% on the day
Market cap
$14.5M
Nano cap
Revenue · 2025
$39K
+9.2% on 2024
Net income · 2025
-$3.6M
-9366.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CUPR on Nasdaq |
| Sector | Health Care |
| Industry | Industrial Specialties |
| Country | Singapore |
| IPO year | 2025 |
| SEC CIK | 0001995704 |
| SEC industry code | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $39K |
| Net income | -$3.6M |
| Operating income | -$3.8M |
| Net margin | -9366.7% |
| Operating margin | -9680.1% |
| Revenue growth | +9.2% |
| Cash | $2.4M |
| Total assets | $6.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 374.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-09-16 |
| Latest annual report | 20-F | 2026-04-27 |
| Latest quarterly / interim | 6-K | 2026-10-02 |
Source: SEC EDGAR submissions feed, 101 recent filings. All filings on EDGAR.
Peers in Industrial Specialties
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ADSEW | ADS-TEC ENERGY PLC Warrant | $0.1901 | -20.76% | $14.3M |
| HSCS | HeartSciences Inc. | $3.09 | -6.36% | $15.0M |
| FGI | FGI Industries Ltd. | $7.19 | -5.77% | $13.9M |
| TLIH | Ten-League International Holdings Limited | $5.72 | -0.09% | $16.8M |
| LFWD | Lifeward Ltd. | $6.10 | -1.93% | $17.3M |
| RGNT | Regentis Biomaterials Ltd. | $1.63 | -0.31% | $11.4M |
| CLGN | CollPlant Biotechnologies Ltd | $3.91 | -2.74% | $7.4M |
| MLSS | Milestone Scientific Inc. | $0.3400 | -2.30% | $30.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier